NGM Bio

0 followers


NGM Biopharmaceuticals, Inc. (Nasdaq: NGM) is harnessing powerful human biology to radically reshape the treatment of some of today's toughest diseases.

Industries

Employees

201-500

Links

Org chart

David J. Woodhouse
Chief Executive Officer

David J. Woodhouse

Collapse
Vladimir Hanes
VP, Clinical Development Oncology
Diana Peng Bockus
Head of Business Development
Mahi Saraf
Associate Director, People & Culture
Daniel Kaplan
Chief Scientific Officer
Joanne Sloan Lancaster
VP, Project Team Leadership, Clinical Research
Holly Mueller
Senior Director & Corp Counsel
Jean-Frederic Viret
Chief Financial Officer
Wendy Yeh
Chief Medical Officer
Lulu Sterling
Senior Director, Biometrics
Fatima Larry
Director, Medical Writing
Annika Dansson
Clinical Trial Masterfile Manager